Posted on June 16, 2021
Zantac Lawsuits Allege Popular Heartburn Medication Causes Cancer
Most people have experienced heartburn or gastroesophageal reflux at some point in their lives. People with stomach or intestinal disorders often turn to prescription or over-the-counter antacids to help relieve their symptoms. Most believe that medicines available in pharmacies are safe.
However, sometimes the drug needs to be withdrawn due to the risk The popular drug Zantac was recalled after it was found that it could increase the risk of cancer in consumers. If you or a loved one has been diagnosed with cancer after taking Zantac, you should know that you may have eligibility for filing a ranitidine cancer lawsuit via https://www.zantacantacidcancerlawsuit.com/generic-zantac-lawsuit.asp on the faulty drugs.
Image Source: Google
Basic information about Zantac issues:
Zantac is a brand name of a medicine called ranitidine. It is an H2 blocker used to heal the problem of heartburn. Concerns about the drug’s safety were first raised because the active ingredient of ranitidine such as HCl divided down into a chemical called nitrosodimethylamine (NDMA). The International Agency for Research on Cancer (IARC) classifies NDMA as possibly carcinogenic to humans.
NDMA has been linked to many types of cancer, including:
- Stomach cancer
- Esophageal cancer
- Small bowel cancer
- Colon cancer
- Heart cancer
- Pancreatic cancer
- Prostate cancer
- Multiple myeloma
- Non-Hodgkin’s Lymphoma
Who is entitled to compensation for Zantak’s cancer lawsuit?
If you or a loved one have used Zantac or a generic version of the drug, you may wonder if you are entitled to financial compensation. To qualify for a deal or award at Zantac, you need to prove a few things. First of all, you need to prove that you have taken medication. Lastly, you need to prove that you have suffered losses such as medical bills or lost income due to your cancer. A personal injury attorney familiar with Zantac’s lawsuits can help you determine if you qualify for damages.